PMID: 11926127Apr 3, 2002Paper

Recombinant antibodies for the selective targeting of tumor neovasculature

Current Opinion in Drug Discovery & Development
F VitiDario Neri

Abstract

Angiogenesis, the sprouting of new blood vessels from preexisting ones, is a characteristic feature of many aggressive solid tumors. Advances in the identification of markers of angiogenesis and new methodologies for the production of human recombinant antibodies are making it possible to deliver bioactive molecules to the tumor neovasculature in a selective fashion. This review illustrates how recombinant antibody derivatives may open new avenues for the imaging and therapy of angiogenesis-related diseases, such as cancer, blinding ocular disorders and rheumatoid arthritis.

Related Concepts

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Related Papers

News in Physiological Sciences : an International Journal of Physiology Produced Jointly by the International Union of Physiological Sciences and the American Physiological Society
C HalinDario Neri
Critical Reviews in Therapeutic Drug Carrier Systems
C Halin, Dario Neri
European Journal of Nuclear Medicine and Molecular Imaging
Simon S BrackDario Neri
© 2022 Meta ULC. All rights reserved